Title Health Products: Recovery in China after the clampdown is uninspiring so far
  Networking: China grants 5G licenses, network buildout will accelerate
  5G Industry: Carriers spending; device makers to reach operational tipping point
  Health Foods: Buy TCI (8436 TT) and Grape King (1707 TT)
  Auto Component OEM: Weak Golden September in China; waiting for policy stimulus
  High-frequency/high-speed data transfer PCB: ABF and CCL enjoy lucrative outlook
  Passive Component: Yageo is our only passive component Buy call
  Footwear: Nike¡¦s 4Q18 beat, FY2019 sales guidance raised¡XBuy Feng Tay
  Apple Supply Chain: Apple’s FY3Q18 guidance sparks supply chain optimism
  Auto Components (AM): AM business dented by FX
 
More Titles
Title:Health Products: Recovery in China after the clampdown is uninspiring so far
Download File:Health product Industry note_190715 -- sinopac.pdf 
 
Summary:- Grape King Bio: Maintain Buy; Adjust TP to NT$226 (22x 2019F P/E) from NT$234 on new earnings estimate
  
Date:2019/07/15
Author:TaiwanResearch.com
Register online at Become Member to receive Taiwan research services. For more information, contact TaiwanResearch.com. Tel (8862) 2316-5181
©2001, 2000, 1999 SinoPac All rights reserved. Additional copyright information applies.